Multiple government agencies are responsible for policy-making and for monitoring the pharmaceutical industry in China. (Click the image to download in full size.)
The key stakeholders who are involved in drug approvals in China are:
- Drug manufacturers
- Distributors
- Central government: various agencies
- Provincial government: various agencies
- Hospitals: various classes and levels
- KOLs and physicians
For more information about the regulatory framework in China, please see Pharmaceutical and API Product Registration in China.
You are welcome to use or share this infographic online or in your presentations and papers, as long as you include credits to Pacific Bridge Medical (www.pacificbridgemedical.com) and, if possible, a link back to the source.